Development and validation of spectrofluorimetric method for determination of haloperidol in pharmaceutical dosage forms

Drug Testing and Analysis

Volumn 2, Issue 5, 2010, Pages 252-258

  Rahman, Nafisur ^a   Siddiqui, Sana ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Alizarin red S; Haloperidol; Pharmaceuticals; Spectrofluorimetry; Validation

Indexed keywords

DRUG PRODUCTS; FLUORESCENCE;

ALIZARIN RED; ALIZARIN RED S; FLUORESCENCE INTENSITIES; HALOPERIDOL; ION-PAIR COMPLEXES; PHARMACEUTICAL DOSAGE FORMS; PHARMACEUTICAL PREPARATIONS; SPECTROFLUORIMETRIC METHODS; SPECTROFLUORIMETRY; VALIDATION;

CHLORINE COMPOUNDS;

ALIZARIN RED S; CHLOROFORM; HALOPERIDOL;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG DOSAGE FORM; FLUORESCENCE; ION PAIR EXTRACTION; PH; PRIORITY JOURNAL; SPECTROFLUOROMETRY; STOICHIOMETRY; VALIDATION STUDY;

EID: 77953427682     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.126     Document Type: Article

References (29)

1. T. Z. Peng, Z. P. Yang, R. S. Lu, Talanta 1991, 38, 741.
2. F. S. Ser, M. Veljkovie, M. Lazovie I. Tomie-Pavlovie, J. Europ. Acad. Dermat. Venerol., 1997, 9, 5237.
3. The United States Pharmacopia, 31st edn, The United States Pharmacopoeial Convention: Rockville, MD, USA, 2008, p. 2317.
4. M. Lauro, G. Maria, B. Claudio, B. Giancarlo, R. Maria Augusta, Anal. Bioanal. Chem. 2007, 388, 235.
5. A. Imran, A. Hassan, J. Liq. Chrom. & Rel. Technol. 2005, 28, 3169.
6. Y. Higashi, M. Kitahara, Y. Fujii, Biomed. Chromatogr. 2006, 20, 166.
7. H. Y. Aboul-Enein, I. Ali, H. Hoenen, Biomedical Chromatogr. 2006, 20, 760.
8. R. Petkovska, A. Dimitrovska, Acta Pharm. 2008, 58, 243.
9. H. Trabelsi, S. Bouabdallah, K. Bouzouita, F. Safta, J. Pharm. Biomed. Anal. 2002, 29, 649.
10. R. Driouichl, H. Trabelsi, K. A. Bouzouita, Chromatographia. 2001, 53, 629.
11. K. Naoya, H. Chiyuki, I. Yoshihiro, O. Yoshihito, N. Kenichiro, T. Yashuhiro, K. Naotaka, Anal. Bioanal. Chem. 2006, 386, 719.
12. P. Cutroneo, M. Belijean, R. Phan Tan Luuc, A. M. Siouffi, J. Pharm. Biomed. Anal. 2006, 41, 333.
13. T. Arinobu, H. Hattori, M. Iwai, A. Ishii, T. Kumazawa, O. Suzuki, H. Seno, J. Chromatogr. B. 2002, 776, 107.
14. S. S. Singh, K. Sharma, Anal. Chim. Acta. 2005, 551, 159.
15. S. Carolina, M. Maria, A. Elena, Forensic Sci. Int. 2005, 155, 193.
16. M. Sigrid, N. Mario, V. Mario, D. Marta, J. Sep. Sci. 2007, 30, 772.
17. H. S. EL- Desoky, M. M. Ghoneim, J. Pharm. Biomed. Anal. 2005, 38, 543.
18. F. Huang, Y. Peng, G. Jin, S. Zhang, J. Kong, Sensors. 2008, 8, 1879.
19. S. Mojtaba, S. Leila, T. Zehra, H. Soheila, J.Pharm.Biomed.Anal.2007, 43, 1116.
20. M. Kurzawa, A. Kowalezyk-Marzec, E. Szlyk, Chem Anal. 2004, 49, 91.
21. I. Ganescu, A. Ganescu, I. Papa, A. Reiss, C. Ionescu, Seria Chimie. 2004, 33, 39.
22. C. V. N. Prasad, C. Parivar, T. Chowdhary, T. Rama, S. Purohit, P. Parimoo, Pharm. Pharmacol. Commun. 1998, 4, 325.
23. S. Ouanes, M. Kallel, H. Trabels, F. Safta, K. Bouzouita, J. Pharm. Biomed. Anal. 1998, 17, 361.
24. W. Baeyens, P. De Moerloose, Pharmazie. 1977, 32, 764.
25. W. Baeyens, Pharm. Week bl. 1977, 112, 681.
26. International Conference on Harmonisation, ICH Harmonised Tripartite Guideline- Text on Validation of Analytical Procedures. Fed. Regist. 1995, 60, 11260.
27. D.M. Shingbal, S. V. Joshi, Indian Drugs. 1985, 22, 326.
28. L.Werner, D. F. Boltz, Anal. Chem. 1971, 43, 1265.
29. Canada Health Protection Branch, Drugs Directorate guidelines, Acceptable methods, Ministry of National Health and Welfare, Draft: Ottawa, Canada, 1992.